Renalytix plc American Depositary Shares
RNLX
RNLX was delisted on the 7th of October, 2024.
1 hedge funds and large institutions have $2.2K invested in Renalytix plc American Depositary Shares in 2025 Q1 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 2 closing their positions.
67% less funds holding
Funds holding: 3 → 1 (-2)
84% less capital invested
Capital invested by funds: $13.6K → $2.2K (-$11.4K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
Top Sellers
| 1 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$6.89K |
| 2 |
BBA
Baader Bank Aktiengesellschaft
Unterschleissheim,
Germany
|
-$4.57K |
RNLX Hedge Fund Activity: Q1 2025 in Review
1 of the 7,457 institutional investors tracked by Wall St. Rank reported a position in Renalytix plc American Depositary Shares (RNLX) for Q1 2025, worth a combined $2.2K — down 84% from $13.6K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of RNLX and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was XTX Topco, exiting entirely with an estimated $6.89K sold.
- 1 institutional investor held Renalytix plc American Depositary Shares (RNLX) as of Q1 2025, down from 3 in Q4 2024.
- Funds reported $2.2K of Renalytix plc American Depositary Shares stock for Q1 2025, down 84% quarter-over-quarter.
- 0 funds opened new Renalytix plc American Depositary Shares positions in Q1 2025 and 2 closed out, a net change of -2 holders.
- The largest Renalytix plc American Depositary Shares seller in Q1 2025 was XTX Topco, an estimated $6.89K sold.
Based on aggregated 13F filings for Q1 2025.